210 related articles for article (PubMed ID: 6133543)
21. Effect of 14 years of antihypertensive treatment on renal function and urinary albumin excretion in primary hypertension.
Siewert-Delle A; Ljungman S; Hartford M; Wikstrand J
Am J Hypertens; 1996 Sep; 9(9):841-9. PubMed ID: 8879339
[TBL] [Abstract][Full Text] [Related]
22. An analysis of blood pressure effects of nipradilol and prizidilol in normotensive and spontaneously hypertensive rats.
Watanabe TX; Sokabe H; Kawashima K
Jpn J Pharmacol; 1985 Jul; 38(3):273-9. PubMed ID: 3903298
[TBL] [Abstract][Full Text] [Related]
23. Effect of carvedilol on ambulatory blood pressure, renal hemodynamics, and cardiac function in essential hypertension.
Dupont AG; Van der Niepen P; Taeymans Y; Ingels M; Piepsz A; Bossuyt AM; Block P; Six RO; Jonckheer MH; Vanhaelst L
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S130-6. PubMed ID: 2454359
[TBL] [Abstract][Full Text] [Related]
24. Effect of nebivolol, a novel beta 1-selective adrenoceptor antagonist with vasodilating properties, on kidney function.
Greven J; Gabriëls G
Arzneimittelforschung; 2000 Nov; 50(11):973-9. PubMed ID: 11148863
[TBL] [Abstract][Full Text] [Related]
25. The effect of oral fenoldopam (SKF 82526-J), a peripheral dopamine receptor agonist, on blood pressure and renal function in normal man.
Harvey JN; Worth DP; Brown J; Lee MR
Br J Clin Pharmacol; 1985 Jan; 19(1):21-7. PubMed ID: 2858215
[TBL] [Abstract][Full Text] [Related]
26. Renal and systemic effects of the renin inhibitor remikiren in patients with essential hypertension.
van Paassen P; de Zeeuw D; de Jong PE
J Cardiovasc Pharmacol; 1995 Jul; 26(1):39-45. PubMed ID: 7564363
[TBL] [Abstract][Full Text] [Related]
27. Effect of short-term administration of cromakalim on renal hemodynamics and eicosanoid excretion in essential hypertension.
Lebel M; Grose JH; Lacourcière Y
Am J Hypertens; 1991 Sep; 4(9):740-4. PubMed ID: 1834087
[TBL] [Abstract][Full Text] [Related]
28. Effects of cadralazine on systemic blood pressure, renal function and plasma renin activity in anesthetized dogs.
Yukimura T; Miura K; Tanaka M; Higashio T; Sakaguchi S; Kuroda K; Yamamoto K
Arzneimittelforschung; 1988 Jan; 38(1):25-8. PubMed ID: 3284531
[TBL] [Abstract][Full Text] [Related]
29. Comparative effects of the angiotensin II receptor blocker EXP 3174 and of the angiotensin-converting enzyme inhibitor captopril on renal glomerular hemodynamics in the dog.
Heller J; Kramer HJ; Horácek V
Kidney Blood Press Res; 1997; 20(6):391-7. PubMed ID: 9453450
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular and renal profile of acute peripheral dopamine1-receptor agonism with fenoldopam.
Glück Z; Jossen L; Weidmann P; Gnädinger MP; Peheim E
Hypertension; 1987 Jul; 10(1):43-54. PubMed ID: 2885268
[TBL] [Abstract][Full Text] [Related]
31. Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal function.
van Paassen P; de Zeeuw D; Navis G; de Jong PE
Nephrol Dial Transplant; 2000 May; 15(5):637-43. PubMed ID: 10809804
[TBL] [Abstract][Full Text] [Related]
32. Effects of felodipine on renal function in animals.
DiBona GF
Drugs; 1985; 29 Suppl 2():168-75. PubMed ID: 3987545
[TBL] [Abstract][Full Text] [Related]
33. Prizidilol, an antihypertensive with precapillary vasodilator and beta-adrenoceptor blocking actions, in primary hypertension.
Larsson R; Karlberg BE; Norlander B; Wirsén A
Clin Pharmacol Ther; 1981 May; 29(5):588-93. PubMed ID: 6111409
[TBL] [Abstract][Full Text] [Related]
34. Effects of intensified blood-pressure reduction on renal function and albumin excretion in primary hypertension. Addition of felodipine or ramipril to long-term treatment with beta-blockade.
Siewert-Delle A; Ljungman S; Hartford M; Wikstrand J
Am J Hypertens; 1995 Feb; 8(2):113-23. PubMed ID: 7755939
[TBL] [Abstract][Full Text] [Related]
35. Changes in renal function induced by endralazine, a new antihypertensive drug.
Wegmüller E; Reubi FC
Eur J Clin Pharmacol; 1983; 24(3):307-14. PubMed ID: 6345175
[No Abstract] [Full Text] [Related]
36. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
Bauer JH; Reams GP
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
[TBL] [Abstract][Full Text] [Related]
37. Renal hemodynamic effects of tertatolol in essential hypertension.
Paillard F; Lantz B; Leviel F; Ardaillou R
Am J Nephrol; 1986; 6 Suppl 2():40-4. PubMed ID: 2879472
[TBL] [Abstract][Full Text] [Related]
38. Prizidilol, a combined vasodilatory and beta-adrenoceptor blocking drug, in primary hypertension. A long-term efficacy, tolerance and pharmacokinetic study.
Karlberg BE; Larsson R; Ohman KP; Norlander B; Wirsen A; Hed J; Lundh BL; Flock A
Eur J Clin Pharmacol; 1983; 25(2):179-86. PubMed ID: 6138257
[TBL] [Abstract][Full Text] [Related]
39. Acute systemic and renal haemodynamic effects and long-term antihypertensive action of cadralazine in patients pretreated with beta-blockers and diuretics.
Persson B; Granerus G; Wysocki M; Hedner T; Andersson OK
Eur J Clin Pharmacol; 1987; 31(5):513-8. PubMed ID: 2881788
[TBL] [Abstract][Full Text] [Related]
40. Effect of captopril on renal vascular tone in patients with essential hypertension.
Mimran A; Brunner HR; Turini GA; Waeber B; Brunner D
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():421s-423s. PubMed ID: 232029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
